Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisaveta Voynova

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cells|November 27, 2021
From Hematopoietic Stem Cell Transplantation to Chimeric Antigen Receptor Therapy: Advances, Limitations and Future PerspectivesElisaveta Voynova, Damian Kovalovsky
Annals of the New York Academy of Sciences|February 12, 2010
Innate pathways to B-cell activation and toleranceSteve P Crampton, Elisaveta Voynova, Silvia Bolland
Journal of Autoimmunity|February 8, 2020
Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndromeElisaveta Voynova, Floryna Lefebvre, Ariful Qadri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2015
Cutting Edge: Induction of Inflammatory Disease by Adoptive Transfer of an Atypical NK Cell SubsetElisaveta Voynova, Chen-Feng Qi, Bethany Scott, et al.
Vaccine|November 18, 2005
Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virusNina Ivanovska, Andrey Tchorbanov, Jozsef Prechl, et al.
Cellular Immunology|August 1, 2017
Role of CD11c<sup>+</sup> T-bet<sup>+</sup> B cells in human health and diseaseJodi L Karnell, Varsha Kumar, Jingya Wang, et al.
Immunology Letters|February 12, 2008
An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytesElisaveta Voynova, Andrey Tchorbanov, Jozsef Prechl, et al.
Immunohorizons|January 5, 2019
Requirement for CD40/CD40L Interactions for Development of Autoimmunity Differs Depending on Specific Checkpoint and Costimulatory PathwaysElisaveta Voynova, Tamer Mahmoud, Lucas T Woods, et al.
Autoimmunity Reviews|February 13, 2010
Re-establishing tolerance to DNA in humanized and murine models of SLEKalina Nikolova, Nikolina Mihaylova, Elisaveta Voynova, et al.
Molecular Immunology|February 27, 2009
Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activityNikolina Mihaylova, Elisaveta Voynova, Andrey Tchorbanov, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cells|November 27, 2021
From Hematopoietic Stem Cell Transplantation to Chimeric Antigen Receptor Therapy: Advances, Limitations and Future PerspectivesElisaveta Voynova, Damian Kovalovsky
Annals of the New York Academy of Sciences|February 12, 2010
Innate pathways to B-cell activation and toleranceSteve P Crampton, Elisaveta Voynova, Silvia Bolland
Journal of Autoimmunity|February 8, 2020
Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndromeElisaveta Voynova, Floryna Lefebvre, Ariful Qadri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2015
Cutting Edge: Induction of Inflammatory Disease by Adoptive Transfer of an Atypical NK Cell SubsetElisaveta Voynova, Chen-Feng Qi, Bethany Scott, et al.
Vaccine|November 18, 2005
Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virusNina Ivanovska, Andrey Tchorbanov, Jozsef Prechl, et al.
Cellular Immunology|August 1, 2017
Role of CD11c<sup>+</sup> T-bet<sup>+</sup> B cells in human health and diseaseJodi L Karnell, Varsha Kumar, Jingya Wang, et al.
Immunology Letters|February 12, 2008
An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytesElisaveta Voynova, Andrey Tchorbanov, Jozsef Prechl, et al.
Immunohorizons|January 5, 2019
Requirement for CD40/CD40L Interactions for Development of Autoimmunity Differs Depending on Specific Checkpoint and Costimulatory PathwaysElisaveta Voynova, Tamer Mahmoud, Lucas T Woods, et al.
Autoimmunity Reviews|February 13, 2010
Re-establishing tolerance to DNA in humanized and murine models of SLEKalina Nikolova, Nikolina Mihaylova, Elisaveta Voynova, et al.
Molecular Immunology|February 27, 2009
Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activityNikolina Mihaylova, Elisaveta Voynova, Andrey Tchorbanov, et al.
Pageof 2